Stay updated on Mepolizumab Clinical Trial for HES & Severe Asthma
Sign up to get notified when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.

Latest updates to the Mepolizumab Clinical Trial for HES & Severe Asthma page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe webpage has updated its version from v2.15.0 to v2.15.2 and removed several outdated dates from 2020, replacing them with new dates in April 2025.SummaryDifference0.7%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about the Hypereosinophilic Syndrome study, specifically the EudraCT number and the revision number, while removing detailed descriptions of previous studies and their criteria.SummaryDifference65%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Mepolizumab Clinical Trial for HES & Severe Asthma
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.